Home

Continuazione ispezione Skalk nejm clinical videos topo tra fioritura

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM

IV Fluid Restriction in Septic Shock | NEJM
IV Fluid Restriction in Septic Shock | NEJM

Adagrasib in <i>KRAS<sup>G12C</sup></i>-Mutated Lung Cancer | NEJM
Adagrasib in <i>KRAS<sup>G12C</sup></i>-Mutated Lung Cancer | NEJM

Oncolytic Virus for Pediatric Pontine Glioma | NEJM
Oncolytic Virus for Pediatric Pontine Glioma | NEJM

L9LS Monoclonal Antibody for Malaria Prevention | NEJM
L9LS Monoclonal Antibody for Malaria Prevention | NEJM

Empagliflozin in HF with Preserved Ejection Fraction | NEJM
Empagliflozin in HF with Preserved Ejection Fraction | NEJM

Surgery articles: The New England Journal of Medicine
Surgery articles: The New England Journal of Medicine

Balanced Multielectrolyte Solution vs. Saline in ICUs | NEJM
Balanced Multielectrolyte Solution vs. Saline in ICUs | NEJM

Intravenous Vitamin C for Sepsis in the ICU | NEJM
Intravenous Vitamin C for Sepsis in the ICU | NEJM

Trastuzumab Deruxtecan for Breast Cancer | NEJM
Trastuzumab Deruxtecan for Breast Cancer | NEJM

Sotrovimab for Early Covid-19 | NEJM
Sotrovimab for Early Covid-19 | NEJM

Time-Restricted Eating for Weight Loss | NEJM
Time-Restricted Eating for Weight Loss | NEJM

Hepatopulmonary Syndrome | NEJM
Hepatopulmonary Syndrome | NEJM

NEJM Group - YouTube
NEJM Group - YouTube

Once-Weekly Tirzepatide for Obesity | NEJM
Once-Weekly Tirzepatide for Obesity | NEJM

Lenacapavir in Multidrug-Resistant HIV-1 Infection | NEJM
Lenacapavir in Multidrug-Resistant HIV-1 Infection | NEJM

Respiratory Syncytial Virus Vaccine Study | NEJM
Respiratory Syncytial Virus Vaccine Study | NEJM

BNT162b2 Covid-19 Vaccine in 5-to-11-Year-Old Children | NEJM
BNT162b2 Covid-19 Vaccine in 5-to-11-Year-Old Children | NEJM

CV and Cancer Risk with Tofacitinib in RA | NEJM
CV and Cancer Risk with Tofacitinib in RA | NEJM

Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJM
Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJM

Metformin, Ivermectin, and Fluvoxamine for Covid-19 | NEJM
Metformin, Ivermectin, and Fluvoxamine for Covid-19 | NEJM

CT in Stable Chest Pain | NEJM
CT in Stable Chest Pain | NEJM

Phase 1–2 Trial of Gene Therapy for Hemophilia B | NEJM
Phase 1–2 Trial of Gene Therapy for Hemophilia B | NEJM

Clinical Features of VITT | NEJM
Clinical Features of VITT | NEJM

Fourth Dose of BNT162b2 Covid-19 Vaccine | NEJM
Fourth Dose of BNT162b2 Covid-19 Vaccine | NEJM

Ublituximab in Relapsing Multiple Sclerosis | NEJM
Ublituximab in Relapsing Multiple Sclerosis | NEJM

Convalescent Plasma for Covid-19 in Outpatients | NEJM
Convalescent Plasma for Covid-19 in Outpatients | NEJM

NVX-CoV2373 Covid-19 Vaccine | NEJM
NVX-CoV2373 Covid-19 Vaccine | NEJM

Tranexamic Acid in Noncardiac Surgery | NEJM
Tranexamic Acid in Noncardiac Surgery | NEJM